Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study

<div>Kaplan–Meier cumulative event curves for (a) major adverse cardiovascular events (MACE), (b) cardiac death, (c) myocardial infarction (MI), (d) definite/probable stent thrombosis (ST), (e) target lesion revascularization (TLR), and (f) clinically relevant bleeding according to PCI complexity and HBR status.</div>

Journal of Interventional Cardiology

fig2

Figure 2

Figure 2: Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study 

Figure 2 | Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study 